๐ต๏ธ Avadel Pharmaceuticals PLC ($AVDL)
SEC insider & ownership activity, last 12 months ยท CIK 1012477 ยท every row links its SEC filing
Over the last 12 months insiders sold $233.4M with no open-market buying against it. Weiss Asset Management LP sold $233.4M in discretionary trades (Feb). One red-flag 8-K in the window: Delisting notice (3.01), Feb 12, 2026.
Insider flow
0 buyers, $0 (0 lots) ยท 1 seller, $233.4M (1 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Weiss Asset Management LP | 0 | โ | 1 | $233.4M | Feb 13, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Blackrock, Inc. | 7.0% | 13G | Jul 16, 2025 | filing โ | |
| The Vanguard Group | 5.7% | 13G | Jul 29, 2025 | filing โ | |
| Janus Henderson Biotech Innovation Master Fund Ltd | 5.4% | 13G | May 14, 2025 | filing โ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Agreement terminated (1.02) | Feb 12, 2026 | filing โ |
| Acquisition or disposition (2.01) | Feb 12, 2026 | filing โ |
| Delisting notice (3.01) | Feb 12, 2026 | filing โ |
| Material Modifications to Rights of Security Holders (3.03) | Feb 12, 2026 | filing โ |
| Change of control (5.01) | Feb 12, 2026 | filing โ |
| Officer/director changes (5.02) | Feb 12, 2026 | filing โ |
| Charter/bylaw changes (5.03) | Feb 12, 2026 | filing โ |
| Reg FD disclosure (7.01) | Feb 12, 2026 | filing โ |
| Financial Statements and Exhibits (9.01) | Feb 12, 2026 | filing โ |
| Other events (8.01) | Jan 19, 2026 | filing โ |
| Shareholder vote (5.07) | Jan 12, 2026 | filing โ |
| Other events (8.01) | Jan 12, 2026 | filing โ |
| Financial Statements and Exhibits (9.01) | Jan 12, 2026 | filing โ |
| Reg FD disclosure (7.01) | Dec 18, 2025 | filing โ |
| Other events (8.01) | Dec 18, 2025 | filing โ |
| Financial Statements and Exhibits (9.01) | Dec 18, 2025 | filing โ |
| Other events (8.01) | Dec 8, 2025 | filing โ |
| Material agreement (1.01) | Nov 18, 2025 | filing โ |
| Reg FD disclosure (7.01) | Nov 18, 2025 | filing โ |
| Financial Statements and Exhibits (9.01) | Nov 18, 2025 | filing โ |
| Other events (8.01) | Nov 17, 2025 | filing โ |
| Financial Statements and Exhibits (9.01) | Nov 17, 2025 | filing โ |
| Other events (8.01) | Nov 14, 2025 | filing โ |
| Financial Statements and Exhibits (9.01) | Nov 14, 2025 | filing โ |
| Earnings (2.02) | Nov 4, 2025 | filing โ |
| Financial Statements and Exhibits (9.01) | Nov 4, 2025 | filing โ |
| Material agreement (1.01) | Oct 22, 2025 | filing โ |
| Reg FD disclosure (7.01) | Oct 22, 2025 | filing โ |
| Financial Statements and Exhibits (9.01) | Oct 22, 2025 | filing โ |
| Material agreement (1.01) | Oct 21, 2025 | filing โ |